Sunogel Wins First Prize
Baltimore, Sunogel Biotechnologies, Inc. (“Sunogel” or “the Company”), a leader in deep dermal wound healing research, committed to scientific excellence and patient care wins first prize at the Overseas Talent Innovation and Entrepreneurship Awards, Changchun.
Hosted by the China Association for Science and Technology the Overseas Talent Innovation and Entrepreneurship Awards recognizes pragmatic innovation and exceptional application of technology to transform and grow businesses.
From over 350 original entries from 25 countries and 60 finalists, Sunogel’s Pro-Regenerative Hydrogels was one of only three first prize winners.
Dr Guoming Sun, Chief Executive Officer of Sunogel, commented:
“I would like to thank the awards’ organizers for hosting such a wonderful event. Winning first prize further demonstrates the potential of our technology and validates our research. We anticipate our product pipeline will deliver truly meaningful innovation to the wound care market. We will continue to innovate as we progress towards the clinic.”
Sunogel Wins First Prize
Baltimore, Sunogel Biotechnologies, Inc. (“Sunogel” or “the Company”), a leader in deep dermal wound healing research, committed to scientific excellence and patient care wins first prize at the Overseas Talent Innovation and Entrepreneurship Awards, Changchun.
Hosted by the China Association for Science and Technology the Overseas Talent Innovation and Entrepreneurship Awards recognizes pragmatic innovation and exceptional application of technology to transform and grow businesses.
From over 350 original entries from 25 countries and 60 finalists, Sunogel’s Pro-Regenerative Hydrogels was one of only three first prize winners.
Dr Guoming Sun, Chief Executive Officer of Sunogel, commented:
“I would like to thank the awards’ organizers for hosting such a wonderful event. Winning first prize further demonstrates the potential of our technology and validates our research. We anticipate our product pipeline will deliver truly meaningful innovation to the wound care market. We will continue to innovate as we progress towards the clinic.”